Etanercept

Last Updated: 09/19/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10451 publications

Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.

Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.

Journal: The Journal of dermatological treatment

Published: September 07, 2026

Switchback from biosimilar tumor necrosis factor-alpha inhibitors to reference medicines: a review.

Switchback from biosimilar tumor necrosis factor-alpha inhibitors to reference medicines: a review.

Journal: Expert review of clinical immunology

Published: September 03, 2026

Rapid Improvement in Cerebral Palsy Following Treatment With Perispinal Etanercept: A Case Report.

Rapid Improvement in Cerebral Palsy Following Treatment With Perispinal Etanercept: A Case Report.

Journal: Cureus

Published: August 21, 2026

Patient-Level Risk Characterization of Drug-Associated Hidradenitis Suppurativa Using Machine Learning.

Patient-Level Risk Characterization of Drug-Associated Hidradenitis Suppurativa Using Machine Learning.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

Disease-modifying antirheumatic drugs for hand osteoarthritis: A systematic review and network meta-analysis.

Disease-modifying antirheumatic drugs for hand osteoarthritis: A systematic review and network meta-analysis.

Journal: Hand surgery & rehabilitation

Published: August 08, 2026

Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy.

Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy.

Journal: Pharmaceutical medicine

Published: July 26, 2026

Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.

Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.

Journal: The Cochrane database of systematic reviews

Published: July 13, 2026

Clinical Relevant Immunosuppressive Drugs Differentially Modulate Axonal Outgrowth from Human Stem Cell-Derived Neurons.

Clinical Relevant Immunosuppressive Drugs Differentially Modulate Axonal Outgrowth from Human Stem Cell-Derived Neurons.

Journal: bioRxiv : the preprint server for biology

Published: July 11, 2026

Clinical Relevant Immunosuppressive Drugs Differentially Modulate Axonal Outgrowth from Human Stem Cell-Derived Neurons.

Clinical Relevant Immunosuppressive Drugs Differentially Modulate Axonal Outgrowth from Human Stem Cell-Derived Neurons.

Journal: bioRxiv : the preprint server for biology

Published: July 11, 2026

Tuberculosis Diagnosis and Prevention in Children on Biological Treatment: Clinical Challenges and Considerations.

Tuberculosis Diagnosis and Prevention in Children on Biological Treatment: Clinical Challenges and Considerations.

Journal: Turkish archives of pediatrics

Published: July 02, 2026

Third salvage haematopoietic stem cell transplantation in a child with very early-onset IBD due to interleukin-10 receptor deficiency.

Third salvage haematopoietic stem cell transplantation in a child with very early-onset IBD due to interleukin-10 receptor deficiency.

Journal: BMJ case reports

Published: July 01, 2026

Biologic therapies in pediatric psoriasis: A single-center experience.

Biologic therapies in pediatric psoriasis: A single-center experience.

Journal: Archivos argentinos de pediatria

Published: June 30, 2026

Showing 1-12 of 10,451

Last Updated: 09/19/2026